BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessPetMed Express, Inc. D/B/A 1-800-PETMEDS Announces Its Financial Results for Fiscal 2017 and Its Quarterly Dividend Raised to $0.20 Per ShareBy Nasdaq OMXMay 8, 2017, 12:01 PM UTC